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irculatory failure results in tissue oxygen deficits and tissue carbon dioxide excesses. 1 The increase in tissue Pco 2 develops from the accumulation of CO 2 generated by the aerobic metabolism and from the intracellular buffering of excess hydrogen ions produced by the hydrolysis of high-energy phosphate compounds during tissue hypoxia. 2, 3 The development of tissue hypercapnia is a global phenomenon and occurs in every organ during circulatory failure. 3 The use of gastric tonometry as an indicator of splanchnic perfusion is based on the measurement of luminal Pco 2 as a reflection of intramucosal Pco 2 (Pico 2 ). 4 More recently, sublingual capnometry has been proposed as a noninvasive marker of the severity of circulatory failure. [5] [6] [7] In experimental studies, [5] [6] [7] sublingual capnometry has correlated well with sublingual blood flow, splanchnic blood flow, and gastric Pco 2 . A preliminary clinical study 8 reported that increased levels of sublingual Pco 2 (Pslco 2 ) were observed in patients with circulatory failure. The purpose of this study was to examine the relationship between Pslco 2 and indexes of local and systemic perfusion in patients with circulatory failure.
Materials and Methods
The protocol was approved by the Institutional Research Board of Saint Vincents Hospital. Written informed consent was ob- tained from the proxies or closest relatives of all patients who were admitted to the study. The study population included 25 patients admitted to the medical, coronary, cardiac surgical, or surgical ICUs who had pulmonary artery catheters in place for hemodynamic monitoring. In addition, all patients had evidence of systemic hypoperfusion as manifested by two of the three following criteria: (1) require pressor agents to maintain a mean arterial pressure (MAP) of Ͼ 60 mm Hg; (2) a urine output Ͻ 0.5 mL/kg/h; and (3) an elevated arterial lactate level.
Heart rate was monitored continuously. Arterial pressure was monitored via an arterial catheter in either the radial or the femoral artery. All patients were catheterized with a pulmonary artery catheter. Serial measurements of heart rate, MAP, pulmonary capillary wedge pressure, and central venous pressure were made. Transducers were referenced to the midaxillary line, and all pressures were measured at end-expiration. Cardiac index (Ci) was measured by thermodilution using measurements that varied by Ͻ 10%. Oxyghemoglobin saturation and content were measured with a cooximeter. Arterial, mixed venous, and tonometrically measured carbon dioxide tension were determined by a blood gas analyzer (Stat Profile 5; Nova Biomedical; Waltham, MA). Arterial lactate levels were determined by the enzymatic method (Vitros 950 lactate analyzer; Johnson and Johnson; Rochester, NY). Derived hemodynamic variables were calculated from the following standard formulas: systemic vascular resistance ϭ (MAP Ϫ CVP/Ci) ϫ 80 (where CVP is central venous pressure); systemic oxygen delivery (Do 2 ) ϭ arterial oxygen content ϫ Ci; and oxygen consumption (V o 2 ) ϭ arteriovenous oxygen content difference ϫ Ci.
A tonometric nasogastric tube (TRIP NGS catheter; Tonometrics; Worcester, MA) was inserted, after which radiographic confirmation of the catheter position was obtained. All patients were placed on a regimen of IV famotidine. Phosphate-buffered solution was used to improved the accuracy of the measurements. 9 The intraluminal Pco 2 was measured from 1.5-mL samples that were aspirated from the catheter balloon anaerobically after discarding the first 1 mL. The Pico 2 measurement was multiplied by the appropriate equilibration factor provided by the manufacturer.
Pslco 2 was measured using a disposable CO 2 sensor (Optical Sensors; Minneapolis, MN). It incorporates a CO 2 -specific fluorescent dye in a buffer solution encased in a silicone capsule that is permeable to CO 2 gas. The sensor is attached to an instrument that measures the amount of CO 2 present by projecting light onto the sensor with an optical fiber. Changes in the projected light are used to calculate the amount of CO 2 present. For clinical measurements, the sensor is placed under the tongue with the sensor element facing the sublingual mucosa. Prior to each measurement, the sensor is calibrated against a known standard.
Measurements were taken on entry to the study and at 1, 3, 6, 12, and 24 h after the beginning of the study. Differences between survivors and nonsurvivors were compared by the Mann Whitney U test. Overall correlations between variables for all patients at all times, as well as correlations for individual patients, were analyzed by linear regression. In analyzing the data from individual patients, correlation coefficients were determined only when three or more data points were available for analysis. A p value Ͻ 0.05 was considered to be significant. Data are expressed as the mean Ϯ SE. 
Results
Twenty-five patients were entered into the study. All but one patient survived the 24-h data collection period. The mean age of the patients was 62 Ϯ 4 years, and their APACHE (acute physiology and chronic health evaluation) II scores were 31 Ϯ 2. Twenty-four patients required vasopressor therapy, all of the patients were intubated, and the hospital mortality rate was 80%. Six patients were being treated for cardiac failure, and 19 patients were being treated for sepsis. Data from gastric tonometry were available in nine patients.
The perfusion parameters at study entry are presented in Table 1 . One of 10 patients with gastric tonometric measurements survived. Pslco 2 levels appeared to be lower in survivors than those in nonsurvivors, as did the Pslco 2 -Paco 2 gradient. Although not significantly different on entry into the study, these values were significantly different at the 3-h and 6-h data points (data not presented). The same parameters at 24 h are presented in Table 2 .
Gastric tonometric values were available in only one survivor. Pslco 2 levels were lower in survivors than in nonsurvivors (p ϭ 0.06). The Pslco 2 -Paco 2 gradient was significantly lower in survivors than in nonsurvivors (p Ͻ 0.05). No other significant differ- ences were found between survivors and nonsurvivors in any of the measured variables at any of the data points. Changes in Pslco 2 , lactate, Pico 2 , Pico 2 -Paco 2 gradient, and Pslco 2 -Paco 2 gradient over the study period are presented in Figures 1 and 2 . Correlations between Pslco 2 and the Pslco 2 -Paco 2 gradient with other indexes of perfusion were examined for all patients and all data points (Table 3 ). Significant but weak correlations were observed between Pslco 2 and both Pico 2 and the Pico 2 -Paco 2 gradient. The best correlation was between Pslco 2 and venous Pco 2 (Pvco 2 ). When patients were placed in subsets for cardiac failure and septic shock, differences emerged. Correlations between Pslco 2 and lactate, Pico 2 , and Pico 2 -Paco 2 gradient were significantly greater in patients with cardiac failure than in patients with septic shock (Table 4) . Of interest, the correlation between Pslco 2 and Pvco 2 was greater in patients with septic shock.
Correlations among Pslco 2 , Pslco 2 -PaCO 2 gradient, and other indexes of perfusion for individual patients also were analyzed (Table 5) . Individual patient data for specific relationships varied over a wide range of values.
Discussion
Tissue hypercapnia is a product of circulatory failure. The accumulation of carbon dioxide is the result of the accumulation of CO 2 from the aerobic metabolism and the buffering of excess hydrogen ions generated from the hydrolysis of high-energy phosphate compounds. [1] [2] [3] This pathophysiology is the basis for gastric tonometry, which in several studies 4,10 -12 has been demonstrated to correlate with the severity of perfusion failure and mortality during critical illness. In experimental studies, 6,7 the measurement of Pslco 2 has been found to correlate with measurements of gastric Pico 2 . In a preliminary clinical study, Pslco 2 was correlated with arterial lactate concentration and survival. 8 Our study examined the relationship of Pslco 2 to a number of clinical indexes of tissue perfusion in patients with circulatory failure. Although we observed significant correlations with a number of variables, these correlations were not as strong as previously described in both clinical and experimental studies. 6 -8 Specifically, only a weak correlation was observed between Pslco 2 and Pico 2 , and no correlation was found between Pslco 2 and lactate concentration. Of interest was the observation that the best overall correlation we observed was between Pslco 2 and Pvco 2 .
Tissue hypoperfusion also can be monitored by examining the gradient between tissue Pco 2 and Paco 2 . 12, 13 This gradient has the advantage of incorporating the influence of the level of ventilation on tissue Pco 2 . 13, 14 Widening of the gradient is expected as the severity of perfusion failure increases. In our study, the Pslco 2 -Paco 2 gradient demonstrated generally better, but still relatively weak, correlations with a number of indexes of perfusion, including arterial lactate concentration.
The reason for the differences between our study and the previous clinical report in which strong correlations between arterial lactate concentration and Pslco 2 were described is unclear. One factor that may contribute to the contrasting observations is differences in patient population. Whereas the report by Weil et al 8 involved a large percentage of patients with traumatic injuries, most of our patients had sepsis. As our data suggest, the relationship between Pslco 2 and other indexes of perfusion may vary depending on the subset of patients being [5] [6] [7] In addition, Pslco 2 and gastric Pco 2 correlate relatively well, with reported correlation coefficients of 0.71 and 0.89, respectively. 4 -7 These studies have involved a different methodology for measuring gastric Pco 2 than that used in this study and have involved primarily patients experiencing hemorrhagic shock. We were not able to duplicate this close relationship clinically, particularly in patients with sepsis in whom significant but weak correlations between Pslco 2 and Pico 2 were present. Whether this discrepancy is related to our measuring techniques or to the influence of alterations in regional blood flow during sepsis requires additional study.
Our study was not designed to examine the use of Pslco 2 as a prognostic indicator of survival. Too few patients were studied, and our patient selection did not incorporate an adequate mix of survivors and nonsurvivors. Nevertheless, at 24 h differences in Pslco 2 levels between survivors and nonsurvivors approached statistical significance, and a significantly greater Pslco 2 -Paco 2 gradient gap was evident in nonsurvivors compared to survivors. These differences were also present at the 3-h and 6-h data points. No significant differences between survivors and nonsurvivors were observed when other indexes of perfusion were examined. Accordingly, although it was not the focus of this study, our data are consistent with the report of Weil et al, 8 suggesting a possible role for Pslco 2 as an index of the severity of perfusion failure.
In conclusion, Pslco 2 can be measured in critically ill patients with circulatory failure who require mechanical ventilation. Pslco 2 correlated best with Pico 2 and arterial lactate concentration in patients with cardiac failure and may have a role as an index of the severity of perfusion failure. 
